Top Companies in Norway Pharmaceutical Market
This report lists the top Norway Pharmaceutical companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Norway Pharmaceutical industry.
-
Abbvie
-
Bayer
-
Boehringer Ingelheim
-
GlaxoSmithKline
-
AstraZeneca
*Disclaimer: Top companies sorted in no particular order
Norway PharmaceuticalMarket Concentration
Norway PharmaceuticalCompany List
-
Abbvie
-
AstraZeneca
-
Bayer
-
Boehringer Ingelheim
-
GlaxoSmithKline
-
Roche
-
Bristol-Myers Squibb
-
Eli Lilly and Company
-
Merck
-
Sanofi
Specific to Norway Pharmaceutical Market
Competitive Landscape Report Includes
Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.
Norway Pharmaceutical Market Companies Summary
The pharmaceutical landscape in Norway has been significantly impacted by the COVID-19 pandemic. The government's rapid shutdown measures affected the entire economy, including the operations of pharmaceutical firms and research entities. Despite the country's crucial role in international public-private partnerships to combat COVID-19, criticisms have been raised regarding the timing and extent of demands made on the pharmaceutical sector. This has resulted in a notable impact on the pharmaceutical market in Norway. However, Norway's pharmaceutical market remains an attractive destination for firms looking to establish a base or form partnerships, thanks to its advanced clinical and medical capabilities in key sectors like neuroscience and cancer. The presence of key market players, product launches, and mergers and acquisitions are expected to spur market growth. For instance, a specialty pharmaceutical firm recently launched a first-of-its-kind generic medication in Norway. Furthermore, the inclusion of Norwegian patients in global clinical trials exposes the country's healthcare system to broader perspectives. Despite stringent regulatory rules for pharmaceutical products, the market is expected to grow in the coming years.
Explore MoreNorway Pharmaceutical Companies - Table of Contents
-
1. COMPETITIVE LANDSCAPE
-
1.1 Company Profiles
-
1.1.1 AbbVie Inc.
-
1.1.2 AstraZeneca
-
1.1.3 Bayer AG
-
1.1.4 Boehringer Ingelheim
-
1.1.5 GSK plc
-
1.1.6 F. Hoffmann-La Roche Ltd
-
1.1.7 Bristol Myers Squibb Company
-
1.1.8 Eli Lilly and Company
-
1.1.9 Merck & Co., Inc.
-
1.1.10 Sanofi SA
-
- *List Not Exhaustive
-
Norway Pharmaceutical Companies FAQs
Who are the key players in Norway Pharmaceutical Market?
AbbVie Inc., Bayer AG, Boehringer Ingelheim, GSK plc and AstraZeneca are the major companies operating in the Norway Pharmaceutical Market.